DNA strands in materials act like traffic signals to start, stop cell activity or regenerate tissue
A groundbreaking advancement in materials from Northwestern University could potentially help patients requiring stem cell therapies for spinal cord injuries, stroke, Parkinson’s disease, Alzheimer’s disease, arthritic joints or any other condition requiring tissue regeneration, according to a new study.
“It’s important in the context of cell therapies for people to cure these diseases or regenerate tissues that are no longer functional,” said senior author Samuel I. Stupp, director of Northwestern’s Simpson Querrey Institute for BioNanotechnology and Board of Trustees Professor of Materials Science and Engineering, Chemistry, Medicine and Biomedical Engineering.
Cells in our bodies are constantly being signaled with many types of instructions coming from proteins and other molecules present in the matrices that surround them. For example, these can be cues for cells to express specific genes so they can proliferate or differentiate into several types of cells leading to growth or regeneration of tissues. One of the marvels of this signaling machinery is the built-in capacity in living organisms to make signals stop and re-start as needed, or to switch off one signal and activate a different one to orchestrate very complex processes. Building artificial materials with this type of dynamic capacity for regenerative therapies has been virtually impossible so far.
New technology could be useful in therapies using patient-derived stem cells to regenerate tissue
The new work published today reports the development of the first synthetic material that has the capability to trigger reversibly this type of dynamic signaling. The platform could not only lead to materials that manage stem cells for more effective regenerative therapies, but will also allow scientists to explore and discover in the laboratory new ways to control the fate of cells and their functions.
One of the findings is the possibility of using the synthetic material to signal neural stem cells to proliferate, then at a specific time selected by the operator, trigger their differentiation into neurons and then return the stem cells back to a proliferative state on demand.
The paper also reports that spinal cord neural stem cells, initially grouped into structures known as “neurospheres,” can be driven to spread out and differentiate using a signal. But when this signal is switched off, the cells spontaneously re-group themselves into colonies. This uncovers strong interactions among these cells that could be important in understanding developmental and regenerative cues.
Stem cell proliferation and differentiation can be triggered over multiple cycles with new materials technology
The potential use of the new technology to manipulate cells could help cure a patient with Parkinson’s disease. The patient’s own skin cells could be converted to stem cells using existing techniques. The new technology could help expand the newly converted stem cells in vitro – in the lab – and then drive their differentiation into dopamine-producing neurons before transplantation back to the patient.
In the new technology, materials are chemically decorated with different strands of DNA, each designed to display a different signal to cells. To activate signals to cells, soluble molecules containing complementary DNA strands coupled to peptides are added to the material to create DNA double helices displaying the signal. By adding a few drops of the DNA-peptide conjugate, a green light is given to produce more stem cells. The approach to provide the material with dynamic intelligence is to expose the surface to a soluble single-stranded DNA molecule designed to “grab” the signal-containing strand of the duplex and form a new DNA double helix. This new duplex is no longer attached to the material surface and washes away, thus switching the biological signal off. To turn the signal back on, all that is needed is to now introduce a new copy of single-stranded DNA bearing a signal that will reattach to the material’s surface.
“People would love to have cell therapies that utilize stem cells derived from their own bodies to regenerate tissue,” Stupp said. “In principle, this will eventually be possible, but one needs procedures that are effective at expanding and differentiating cells in order to do so. Our technology does that.”
Starting or stopping cell activity existed before; this research discovered how to re-start and stop again cell activity several times
While this process is currently only done in vitro with the vision of then transplanting cells, Stupp said in the future it might be possible to perform this process in vivo. The stem cells would be implanted in the clinic, encapsulated in the type of material described in the new work, via an injection and targeted to a particular spot. Then the soluble molecules would be given to the patient to manipulate proliferation and differentiation of transplanted cells.
The Latest on: Tissue regeneration
- How bone marrow regenerates after chemotherapyon March 5, 2021 at 7:03 am
Researchers from Osaka University identified the molecular mechanism underlying bone marrow regeneration after chemotherapy. By studying group 2 innate lymphoid cells (ILC2s), a specific subtype of ...
- Acuitive Technologies gains FDA nod for ligament reconstruction deviceson March 4, 2021 at 9:18 pm
Acuitive Technologies received FDA 510(k) clearance for its Citrespline and Citrelock ligament reconstruction devices.
- Acuitive Technologies Enters Sports Medicine Marketon March 4, 2021 at 10:53 am
Inc. today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CITRESPLINE™ and ...
- Hydrogel Injection Could Change Cardiac Tissue Healing After Heart Attackson March 4, 2021 at 12:09 am
Researchers at Spain's University of Valladolid , BIOFORGE Labs , the SFI Research Center and CÚRAM have created a hydrogel injectable that may prevent additional damage and assist in repairing heart ...
- Regenerative Collagen Scaffold Offers Better Options for Reconstruction of Soft Tissue in Surgeryon March 3, 2021 at 9:00 pm
Scientists have developed a novel collagen polymer technology that can be used to fill voids in soft tissue reconstruction surgery. The tissue filler also helps in inducing a regenerative response ...
- Novadip Biosciences receives IND approval from the FDA for regenerative bone product NVD-003on March 3, 2021 at 8:02 pm
Authorization to start clinical trial in the US granted for rare paediatric bone disease Mont-Saint-Guibert, Mar 4, 2021 (GlobeNewswire) - Novadip Biosciences (“Novadip”), a clinical stage company ...
- AgeX Therapeutics and LyGenesis to Negotiate Merger Agreementon March 2, 2021 at 6:26 am
AgeX Therapeutics, Inc. ("AgeX"; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and cell regeneration, and LyGenesis, Inc. ("LyGenesis"), a privately held ...
- New injectable hydrogel could heal cardiac tissue after heart attackon March 1, 2021 at 2:11 pm
Researchers at CÚRAM, the SFI Research Centre for Medical Devices based at National University of Ireland Galway, and BIOFORGE Lab, at the University of Valladolid in Spain, have developed an ...
- Could An Emerging Soft Tissue Regeneration System Have An Impact On Foot And Ankle Care?on March 1, 2021 at 11:36 am
Over 20 years in practice, I have spent a great deal of time looking for a modality that could treat the majority of foot and ankle ailments we see in our practices. When I was in residency, almost ...
- Repair of segmental bone defect using tissue engineered heterogeneous deproteinized bone doped with lithiumon March 1, 2021 at 9:17 am
Lithium have been shown to play an important role in improving the osteogenic properties of biomaterials. This study aims to explore the osteogenic improvement effect of tissue engineered ...
via Google News and Bing News